Play Pause Stop

Wenqin Zhang, Kaiyue Ji, Congcong Min, Cuiping Zhang, Lin Yang, Qi Zhang, Zibin Tian, Mengyuan Zhang, Xinyu Wang, Xiaoyu Li

235
May 7, 2022
Cancer science
DOI :
10.1111/cas.15394
Article Institutional access
show_chart

FAT atypical cadherin 1 (FAT1) is a mutant gene frequently found in human cancers and mainly accumulates at the plasma membrane of cancer cells. Emerging evidence has implicated FAT1 in the progression of gastric cancer (GC). This study intended to identify a regulatory network related to FAT1 in the GC development. Up-regulated expression of FAT1 was confirmed in GC tissues, and silencing FAT1 was observed to result in suppression of GC cell oncogenic phenotypes. Mechanistic investigation results demonstrated that FAT1 upregulated AP-1 expression by phosphorylating c-JUN and c-FOS, while LINC00857 elevated the expression of FAT1 by recruiting a transcription factor TFAP2C. Functional experiments further suggested that LINC00857 enhanced the malignant biological characteristics of GC cells through TFAP2C-mediated promotion of FAT1. More importantly, LINC00857 silencing delayed the tumor growth and blocked epithelial-mesenchymal transition in tumor-bearing mice, which was associated with downregulated expression of TFAP2C/FAT1. To conclude, LINC00857 plays an oncogenic role in GC through regulating the TFAP2C/FAT1/AP-1 axis. Hence, this study contributes to extended understanding of gastric carcinogenesis and LINC00857 may serve as a therapeutic target for GC.

Please Log In to leave a comment.